PR88219

BROOKLINE, Mass., Feb. 24, 2021 /PRNewswire=KYODO JBN/ --

Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant

technology, is proud to announce that AAT and our lead product Algeness(R) were

selected as one of the top two finalists in the recent Terra2 Solutions Skin

Health Innovation Competition, finishing as the top aesthetic innovation and

second overall in this prestigious, global event.

Logo - https://mma.prnewswire.com/media/1443163/Algeness_Logo.jpg

As part of their commitment to investing in and supporting the growth of

innovative skin health competitions, Gore Range Capital partnered with Terra2

Solutions, a global think tank, and DermX Media Group, a leader in dermatology

education, to host the Terra2 Solutions Skin Health Innovation Competition. The

finals of the competition were held during the recent 18th Annual Winter

Clinical Dermatology Conference-Hawaii(R) (WC21) that was held virtually this

year and attracted 3,700 attendees.

Doug Abel, CEO of AAT, commented, "We were very honored that Algeness(R) was

invited to participate in this prestigious competition, pleased to be initially

selected as one of the top four semifinalists to present during WC21, and

delighted to finish as one of the top two as selected by a group of industry

leaders and highly respected physicians. This notable recognition from

potential customers and investors underscores the unique advantages of the

Algeness(R) technology as a differentiator in the global dermal filler market."

Participating companies were invited to present to a panel of expert judges and

providers in the fields of clinical dermatology, aesthetic medicine, and other

aspects of skin health, and executive leaders of pharmaceutical, medical

device, diagnostic, and IT companies. Four semifinalists including AAT

presented their pitch videos to the entire audience during the meeting, and the

two finalists, AAT and Mindera Corporation were given the opportunity to

present a live pitch to be followed by questions from the panel of judges.

"The dermal filler market is one of the most attractive segments in healthcare.

Advanced Aesthetic Technologies has the know-how, the assets, and the

capabilities necessary to bring innovative and differentiated products to this

market. The recent Terra2 Solutions Skin Health Competition recognized AAT's

Algeness(R) as a finalist among the most innovative technologies in medical

skin health in the world," said Humberto Antunes, Founder of Terra2 Solutions,

a Partner at Gore Range, and former global CEO of Galderma Laboratories.

According to board certified dermatologist Valerie Callender, MD, FAAD, of

Callender Dermatology and Cosmetic Center in Glenn Dale, MD, who served as one

of the judges for the Terra2 Solutions competition, "The unique attributes of

Algeness(R) as presented will provide an important addition to the dermal

filler market, filling a need for a product that offers a differentiated

capability for achieving facial shape and contour definition and the potential

for an outstanding safety profile."

Algeness(R) is a patented family of fully resorbable injectable gel implant

dermal fillers that are 100% natural, providing advantages in terms of safety,

skin rejuvenation, and natural looking results both at rest and during facial

movement. Typical clinical advantages include minimal swelling upon injection

and immediately visible results. Algeness(R) holds a CE Mark and is currently

distributed in over 30 countries worldwide. AAT has begun efforts to obtain US

FDA approval.

About Terra2 Solutions Skin Health Innovation Competition

The Terra2 Solutions Skin Health Innovation Competition showcases companies

developing new treatments, diagnostic capabilities, and technologies to improve

the health of our skin. The Competition is an opportunity for Winter Clinical

Dermatology Conference-Hawaii(R) participants to learn about emerging solutions

in clinical dermatology and aesthetic medicine.

https://www.gorerangecapital.com/innovationcompetition

About Advanced Aesthetic Technologies, Inc.

AAT is a fast growing, global corporation developing new technologies for

aesthetic medicine. Our lead products, the Algeness(R) family of injectable

implants, are the culmination of more than 10 years of scientific and clinical

research and were developed with the goal of providing aesthetic injectors

advances in the ability to achieve deep structural support, clean definition,

and exceptional clinical outcomes where the result at the time of treatment is

the final outcome. Algeness(R) is a 100% natural and biodegradable filler based

on purified agarose with a differentiated clinical and safety performance

profile. AAT continuously invests in research and product development to expand

the scientific knowledge on Algeness(R) and agarose as well as in pursuit of

new and innovative technologies to enhance aesthetic medicine and expand our

product portfolio. Algeness(R) is CE Marked, has multiple additional country

level registrations, and is currently available in over 30 countries. AAT is in

the process of pursuing registration in the US through the FDA and also in

China through the partnership with Lanzhou Biotechnique Development Co., LTD

(Lanzhou) and their parent company China National Biotec Group Co., LTD (CNBG).

http://www.algeness.com

About the Winter Clinical Dermatology Conference

For the past 18 years, the Winter Clinical Dermatology Conference-Hawaii(R), a

continuing medical education (CME) event, has provided practitioners, including

dermatologists, dermatologic surgeons, residents, fellows, physician assistants

and nurse practitioners, with a therapeutic update based on real-life

experience of the faculty. https://fallclinical.health

About Terra2 Solutions

Terra2 Solutions is a global think tank focused on exploring and designing

solutions that address the emerging healthcare issues arising from our

progression towards Terra2. Traditional social, demographic, and institutional

dynamics that have driven and defined society for the last 2,500 years is

rapidly changing. This disruption is driven by shifts in age and economic

demographics, globalization trends, and rapid digitalization. The Sars-2-Cov

pandemic has accelerated these trends and created a growing need for

forward-looking products, technologies, and business models.

http://www.terra2solutions.com/

About Gore Range Capital

Gore Range Capital is a venture capital firm investing in early-stage

healthcare businesses with a focus on skin health. The firm blends the hands-on

approach of operationally focused private equity with the early-stage guidance

needed in venture capital. https://www.gorerangecapital.com/

Contact: filler@algeness.com

SOURCE: Advanced Aesthetic Technologies, Inc.